Position in DNTH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,628,985
-$5,413,646 QoQ
Shares Held
37,228
-65.5% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#114
of 267 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNTH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Atom Investors LP holds $106,011,536 across 52 Biotechnology names. DNTH ranks #4 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
73,465 | $8,156,818 | |
| 2 | IMNM |
Immunome Inc.
|
297,489 | $6,303,791 | |
| 3 | RARE |
Ultragenyx Pharmaceutical Inc.
|
171,771 | $5,735,433 | |
| 4 | DNTH |
Dianthus Therapeutics, Inc. /DE/
This page
|
37,228 | $3,628,985 | |
| 5 | CELC |
Celcuity Inc.
|
34,488 | $3,608,134 | |
| 6 | SNDX |
Syndax Pharmaceuticals Inc
|
162,524 | $3,552,774 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
14,179 | $3,470,593 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
13,474 | $3,246,829 |
All Filings in DNTH
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,628,985 | 37,228 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $9,042,631 | 107,753 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,494,450 | 181,860 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,401,845 | 61,038 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||